Research - Gastroenterology Service

This line includes the study of the pathophysiology of colorectal and pancreatic cancer, the prevention of colorectal cancer and research and innovation in digestive endoscopy. The members of the Gastroenterology Service lead the study of the prevention of colorectal cancer, one of the most common tumors in society, both among the general population and in people with genetic susceptibility (hereditary cancer). In addition, the Service is a pioneer in the search for new diagnostic techniques and endoscopic treatment.

This line is aimed at generating knowledge in the area of inflammatory bowel diseases, to provide a direct benefit to patients who have Crohn's disease or will have ulcerative colitis in the near future. The research focuses on the development of new forms of treatment based on cell therapies; the identification of new therapeutic targets susceptible to pharmacological modulation; deepening the knowledge of the genetic and environmental factors responsible for susceptibility and the course of the disease, as well as the optimization of radiological and biochemical diagnostic techniques in order to adapt the treatment to the needs of each patient.